These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27671727)

  • 1. Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing.
    Stacey GN; Coecke S; Price AB; Healy L; Jennings P; Wilmes A; Pinset C; Ingelman-Sundberg M; Louisse J; Haupt S; Kidd D; Robitski A; Jahnke HG; Lemaitre G; Myatt G
    Adv Exp Med Biol; 2016; 856():259-297. PubMed ID: 27671727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges of using pluripotent stem cells for safety assessments of substances.
    Vojnits K; Bremer S
    Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
    Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
    Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
    Sartipy P; Bjorquist P; Strehl R; Hyllner J
    IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
    Kuske B; Pulyanina PY; zur Nieden NI
    Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells and differentiation--a synoptic review of patents granted since 2009.
    Sureshkumar P; Srinivasan SP; Natarajan K; Gaspar JA; Hescheler J; Sachinidis A
    Expert Opin Ther Pat; 2015 Jun; 25(6):663-73. PubMed ID: 25732569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.
    Kim JH; Alderton A; Crook JM; Benvenisty N; Brandsten C; Firpo M; Harrison PW; Kawamata S; Kawase E; Kurtz A; Loring JF; Ludwig T; Man J; Mountford JC; Turner ML; Oh S; da Veiga Pereira L; Pranke P; Sheldon M; Steeg R; Sullivan S; Yaffe M; Zhou Q; Stacey GN
    Stem Cells; 2019 Sep; 37(9):1130-1135. PubMed ID: 31021472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell models for drug discovery and toxicology studies.
    Liu W; Deng Y; Liu Y; Gong W; Deng W
    J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.
    Hoelting L; Klima S; Karreman C; Grinberg M; Meisig J; Henry M; Rotshteyn T; Rahnenführer J; Blüthgen N; Sachinidis A; Waldmann T; Leist M
    Stem Cells Transl Med; 2016 Apr; 5(4):476-87. PubMed ID: 26933043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S; Medine CN; Hay DC
    Toxicology; 2010 Dec; 278(3):250-5. PubMed ID: 20674645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Stem Cell Banking Initiative (ISCBI).
    Stacey GN; Healy L
    Stem Cell Res; 2021 May; 53():102265. PubMed ID: 33799275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of pluripotent stem cell cultures for toxicity testing.
    Pistollato F; Bremer-Hoffmann S; Healy L; Young L; Stacey G
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):239-57. PubMed ID: 22248265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
    Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
    Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content imaging and analysis of pluripotent stem cell-derived cardiomyocytes.
    Földes G; Mioulane M
    Methods Mol Biol; 2013; 1052():29-39. PubMed ID: 23640255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway Based Toxicology and Fit-for-Purpose Assays.
    Clewell RA; McMullen PD; Adeleye Y; Carmichael PL; Andersen ME
    Adv Exp Med Biol; 2016; 856():205-230. PubMed ID: 27671724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.
    Shinde V; Klima S; Sureshkumar PS; Meganathan K; Jagtap S; Rempel E; Rahnenführer J; Hengstler JG; Waldmann T; Hescheler J; Leist M; Sachinidis A
    J Vis Exp; 2015 Jun; (100):e52333. PubMed ID: 26132533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.